Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Betere langetermijnoverleving van gevorderd melanoom met nivolumab plus ipilimumab
dec 2019 | Dermato-oncologie